GSK PLC on Saturday announced positive phase three data that showed potential for its gepotidacin antibiotic to be the "first" in a new class of oral antibiotics for uncomplicated urinary tract infections in "over 20 years".
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,